Suppr超能文献

小鼠对白血病病毒和肿瘤相关抗原的细胞介导免疫。

Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.

作者信息

Herberman R B, Holden H T, Ting C C, Lavrin D L, Kirchner H

出版信息

Cancer Res. 1976 Feb;36(2 pt 2):615-21.

PMID:56223
Abstract

Cell-mediated immune reactions appear to play an important role in resistance against growth of leukemia cells in mice. Possible mechanisms for in vivo protection in two tumor systems are discussed. These tumor models, which are a Friend leukemia virus-induced transplantable tumor, FBL-3, and primary murine sarcoma virus (MSV) -induced tumors, are strongly antigenic; under some conditions, tumors regress completely. In mice with regressing FBL-3 tumors, cell-mediated cytotoxicity was measured by release of [125I]iododeoxyuridine. The response was biphasic, with an initial peak at 10 days and a 2nd peak after 30 days. A boost in reactivity could be elicited by later challenge with tumor cells. All of the reactivity was dependent on T-cells, being eliminated by treatment with anti-theta plus complement. The specificity of the reactions was not completely defined, but it was consistent with Friend type-specific antigen plus broader, common antigens. In mice with regressing MSV tumors, strong cell-mediated cytotoxicity, measured mainly by release of 51Cr, was seen against RBL-5, a Rauscher virus-induced leukemia. A single peak of response occurred at about 14 days after virus inoculation. Upon later challenge with RBL-5 cells, a vigorous and rapid secondary response was elicited, mainly in the region of tumor challenge. This cytotoxic reactivity and in vivo resistance to leukemia.lso was completely dependent on T-cells. In addition, macrophage-mediated inhibition of leukemia cell growth in vitro was seen in this system at the time of peak tumor development. The 51Cr release cytotoxicity was specific and directed primarily against an antigen, MEV-SA1, associated with mouse endogenous C-type viruses. The macrophage-induced growth inhibition appeared to be nonspecific. In both the FBL-3 and MSV tumor systems, protection against tumor growth could be adoptively transferred by immune lymphoid cells. In addition to induction of cell-mediated immunity by tumor cell or virus inoculation, cell-mediated cytotoxic reactivity was found to occur naturally in most young mice. This natural killer activity was quite distinct from the experimentally elicited reactions, being mediated by N-cells, a subpopulation of lymphoid cells with no clearly identifiable cell surface markers. The natural cytotoxicity was also directed against antigenic specificities different from those recognized by the MSV-immune cells. The central issue in all of these studies has been to determine the relationships between the in vitro-detected cell-mediated reactivity and in vivo resistance to leukemia.

摘要

细胞介导的免疫反应似乎在小鼠抵抗白血病细胞生长中发挥重要作用。本文讨论了在两种肿瘤系统中体内保护的可能机制。这些肿瘤模型,一种是由弗瑞德白血病病毒诱导的可移植肿瘤FBL-3,另一种是原发性鼠肉瘤病毒(MSV)诱导的肿瘤,具有很强的抗原性;在某些情况下,肿瘤会完全消退。在FBL-3肿瘤消退的小鼠中,通过释放[125I]碘脱氧尿苷来测量细胞介导的细胞毒性。反应呈双相性,最初在第10天出现峰值,30天后出现第二个峰值。后期用肿瘤细胞攻击可引发反应性增强。所有反应性均依赖于T细胞,用抗θ加补体处理可消除这种反应性。反应的特异性尚未完全明确,但与弗瑞德型特异性抗原以及更广泛的共同抗原一致。在MSV肿瘤消退的小鼠中,主要通过释放51Cr测量到对劳斯氏病毒诱导的白血病RBL-5有强烈的细胞介导细胞毒性。在病毒接种后约14天出现单一反应峰值。后期用RBL-5细胞攻击时,主要在肿瘤攻击部位引发强烈而快速的二次反应。这种细胞毒性反应性以及对白血病的体内抗性也完全依赖于T细胞。此外,在该系统肿瘤发展高峰期,体外观察到巨噬细胞介导的白血病细胞生长抑制。51Cr释放细胞毒性具有特异性,主要针对与小鼠内源性C型病毒相关的抗原MEV-SA1。巨噬细胞诱导的生长抑制似乎是非特异性的。在FBL-3和MSV肿瘤系统中,免疫淋巴细胞可过继性转移对肿瘤生长的保护作用。除了通过肿瘤细胞或病毒接种诱导细胞介导的免疫外,还发现大多数幼鼠自然存在细胞介导的细胞毒性反应。这种自然杀伤活性与实验诱导反应截然不同,由N细胞介导,N细胞是淋巴细胞的一个亚群,没有明确可识别的细胞表面标志物。自然细胞毒性也针对与MSV免疫细胞识别的抗原特异性不同的抗原。所有这些研究的核心问题是确定体外检测到的细胞介导反应性与体内对白血病抗性之间的关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验